# Superluminal Medicines completes USD 120 million Series A financing

On 2024-9-9, according to Xiniu Data, Superluminal Medicines completed USD 120 million Series A financing



Canonical: https://uniquebase.ai/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef
Stable identifier: 012b0b52-17af-4d30-9e8c-80a80b69a5ef
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:23:52.394Z

## Connected profiles

- [Catalio Capital Management](/institutions/catalio-capital-management)
- [Cooley](/institutions/cooley)
- [Eli Lilly](/institutions/eli-lilly)
- [Eli Lilly and Company](/institutions/eli-lilly-and-company)
- [Gaingels](/institutions/gaingels)
- [Insight Partners](/institutions/insight-partners)
- [NVIDIA](/institutions/nvidia)
- [RA Capital Management](/institutions/ra-capital-management)
- [Superluminal Medicines](/companies/superluminal-medicines)

## Sources

- No source links are available for this profile.